Biosource Tech preclinical data

The Vacaville, Calif., company published in vitro results of malaria vaccine produced by genetically engineered tobacco, showing incorporation of the epitopes as measured by ELISA. The altered virus retained its ability to infect tobacco.

As reported in Bio/Technology, genetically stable recombinant viruses were purified to a relatively high yield (0.4 and 1.2 mg/g fresh weight for two mutants, compared to 4.2 mg/g for the wild type virus). ...